Case report: pathological complete response after S-1/oxaliplatin regimen combined with trastuzumab and tislelizumab in patients with locally advanced gastric cancer
In this study, the patient received combination chemotherapy with SOX trastuzumab and tislelizumab and successfully underwent radical surgery with good clinical outcomes. Combined SOX with trastuzumab and tislelizumab may be an effective neoadjuvant chemotherapy regimen.
Authors
- Mingxu Da (ORCID: https://orcid.org/0000-0001-9181-6088)
- Chenglou Zhu (ORCID: https://orcid.org/0000-0002-9787-7436)
- Yaoqi Li (ORCID: https://orcid.org/0000-0002-1826-5547)
- Lingzhi Peng
Institutions
- Gansu Provincial Hospital (CN)
- Lanzhou University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-09-05
- DOI
- https://doi.org/10.3389/fonc.2024.1425572
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Gansu Province